Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction
10.12092/j.issn.1009-2501.2022.06.012
- Author:
Xi CHEN
1
;
Yongjun LI
1
Author Information
1. Department of Cardiology, Southeast University, Zhongda Hospital
- Publication Type:Journal Article
- Keywords:
cardiac repair;
Chinese patent medicine;
myocardial infarction
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2022;27(6):680-688
- CountryChina
- Language:Chinese
-
Abstract:
Myocardial infarction (MI) is a cardiovascular disease with high morbidity and mortality, which seriously endangers human health. Poor ways of repair after MI may damage people's life quality, therefore scientists have been committed to exploring the way of myocardial repair after MI to strive for a better prognosis of these patients. Chinese patent medicines for blood circulation activation have a long history of use in treatment of MI, where they have been shown to attenuate myocardial injury after MI and promote cardiac repair with multiple targets, links and pathways. This review focuses on a few representative Chinese patent medicines for MI and summarizes their pharmacological effects and clinical research in cardiac repair following MI, effectively providing scientific foundation on treating MI with Chinese patent medicines.
